Q2/2023: Revenue growth in all regions (+8 %) and adjusted earnings improvement (EBITDA +21 %)
General Standard/Regulated Market - All German Stock Exchanges - About aap Implantate AGaap Implantate AG is a globally active medical technology company headquartered in Berlin, Germany. The... -Today at 06:19 am- MarketScreener